vs
Side-by-side financial comparison of enCore Energy Corp. (EU) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.
enCore Energy Corp. is the larger business by last-quarter revenue ($12.4M vs $9.2M, roughly 1.3× Foghorn Therapeutics Inc.). enCore Energy Corp. runs the higher net margin — -173.9% vs -234.3%, a 60.4% gap on every dollar of revenue.
Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
EU vs FHTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.4M | $9.2M |
| Net Profit | $-21.5M | $-21.7M |
| Gross Margin | 37.9% | — |
| Operating Margin | -135.9% | -258.2% |
| Net Margin | -173.9% | -234.3% |
| Revenue YoY | — | 223.8% |
| Net Profit YoY | — | -11.1% |
| EPS (diluted) | $-0.11 | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.4M | $9.2M | ||
| Q3 25 | $8.9M | $8.2M | ||
| Q2 25 | $3.7M | $7.6M | ||
| Q1 25 | $18.2M | $6.0M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | — | $6.9M | ||
| Q1 24 | — | $5.0M |
| Q4 25 | $-21.5M | $-21.7M | ||
| Q3 25 | $-4.8M | $-15.8M | ||
| Q2 25 | $-6.3M | $-17.9M | ||
| Q1 25 | $-24.2M | $-18.8M | ||
| Q4 24 | — | $-19.5M | ||
| Q3 24 | — | $-19.1M | ||
| Q2 24 | — | $-23.0M | ||
| Q1 24 | — | $-25.0M |
| Q4 25 | 37.9% | — | ||
| Q3 25 | 43.8% | — | ||
| Q2 25 | 30.8% | — | ||
| Q1 25 | -0.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -135.9% | -258.2% | ||
| Q3 25 | -158.2% | -226.9% | ||
| Q2 25 | -526.1% | -279.2% | ||
| Q1 25 | -85.7% | -385.0% | ||
| Q4 24 | — | -840.5% | ||
| Q3 24 | — | -305.5% | ||
| Q2 24 | — | -386.6% | ||
| Q1 24 | — | -558.3% |
| Q4 25 | -173.9% | -234.3% | ||
| Q3 25 | -53.7% | -194.4% | ||
| Q2 25 | -172.7% | -237.3% | ||
| Q1 25 | -132.9% | -316.4% | ||
| Q4 24 | — | -682.9% | ||
| Q3 24 | — | -244.9% | ||
| Q2 24 | — | -333.6% | ||
| Q1 24 | — | -495.4% |
| Q4 25 | $-0.11 | $-0.35 | ||
| Q3 25 | $-0.03 | $-0.25 | ||
| Q2 25 | $-0.03 | $-0.28 | ||
| Q1 25 | $-0.13 | $-0.30 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.45 | ||
| Q1 24 | — | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | $80.9M |
| Total DebtLower is stronger | $110.0M | — |
| Stockholders' EquityBook value | $229.2M | $-108.5M |
| Total Assets | $430.4M | $198.1M |
| Debt / EquityLower = less leverage | 0.48× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | $80.9M | ||
| Q3 25 | $91.9M | $89.3M | ||
| Q2 25 | $26.9M | $72.6M | ||
| Q1 25 | $29.7M | $61.0M | ||
| Q4 24 | — | $55.5M | ||
| Q3 24 | — | $57.7M | ||
| Q2 24 | — | $138.9M | ||
| Q1 24 | — | $79.3M |
| Q4 25 | $110.0M | — | ||
| Q3 25 | $109.3M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $229.2M | $-108.5M | ||
| Q3 25 | $248.6M | $-89.7M | ||
| Q2 25 | $264.7M | $-76.7M | ||
| Q1 25 | $267.9M | $-61.7M | ||
| Q4 24 | — | $-45.5M | ||
| Q3 24 | — | $-28.3M | ||
| Q2 24 | — | $-14.3M | ||
| Q1 24 | — | $-97.5M |
| Q4 25 | $430.4M | $198.1M | ||
| Q3 25 | $441.9M | $205.0M | ||
| Q2 25 | $359.4M | $226.2M | ||
| Q1 25 | $362.6M | $258.7M | ||
| Q4 24 | — | $284.0M | ||
| Q3 24 | — | $308.4M | ||
| Q2 24 | — | $328.6M | ||
| Q1 24 | — | $255.0M |
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.44× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.9M | $-22.3M |
| Free Cash FlowOCF − Capex | $7.2M | — |
| FCF MarginFCF / Revenue | 57.8% | — |
| Capex IntensityCapex / Revenue | 46.7% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.9M | $-22.3M | ||
| Q3 25 | $-20.3M | $-18.9M | ||
| Q2 25 | $-9.9M | $-21.0M | ||
| Q1 25 | $-7.7M | $-24.0M | ||
| Q4 24 | — | $-24.5M | ||
| Q3 24 | — | $-21.0M | ||
| Q2 24 | — | $-25.5M | ||
| Q1 24 | — | $-29.3M |
| Q4 25 | $7.2M | — | ||
| Q3 25 | $-26.3M | — | ||
| Q2 25 | $-14.1M | $-21.0M | ||
| Q1 25 | $-11.7M | $-24.0M | ||
| Q4 24 | — | $-25.0M | ||
| Q3 24 | — | $-21.3M | ||
| Q2 24 | — | $-25.6M | ||
| Q1 24 | — | $-29.4M |
| Q4 25 | 57.8% | — | ||
| Q3 25 | -296.6% | — | ||
| Q2 25 | -385.2% | -278.2% | ||
| Q1 25 | -64.1% | -403.2% | ||
| Q4 24 | — | -875.3% | ||
| Q3 24 | — | -273.0% | ||
| Q2 24 | — | -371.0% | ||
| Q1 24 | — | -583.1% |
| Q4 25 | 46.7% | 0.0% | ||
| Q3 25 | 68.0% | 0.0% | ||
| Q2 25 | 115.1% | 0.3% | ||
| Q1 25 | 21.7% | 0.5% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 2.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
